The Irish Pharmaceutical Healthcare Association (IPHA) which represents the research based pharmaceutical industry in Ireland, has stated that it will work with initiatives that truly speed up the slow and late access to new medicines for Irish patients.
Meeting hears about unique Swedish IT-based self-care initiative, which builds a ‘flu’ map and encourages patients to visit pharmacies for prevention and treatment
The Irish Pharmaceutical Healthcare Association (IPHA) has welcomed a call from a group of organisations representing patients, healthcare professionals and the health care industry to the EU and UK to prioritise patients in the Brexit negotiations.
The Irish Pharmaceutical Healthcare Association (IPHA), which represents 47-research based pharmaceutical companies in Ireland, has warmly welcomed the latest National Cancer Registry Annual Report.
BioPharmaChemIreland (BPCI)- the Ibec group that represents the sector, alongside the Irish Pharmaceutical Healthcare Association (IPHA) and the National Institute for Bioprocessing Research and Training (NIBRT), have joined forces to promote the biopharmaceutical industry in Ireland as a global powerhouse, generating revenue of €66 billion per annum.
The Irish Pharmaceutical Healthcare Association has welcomed the reduction of prescription charges and the lowering of the Drugs Payment Scheme threshold in today.
Responding to the publication of a study in the British Medical Journal (BMJ) concerning the benefits on overall survival and quality of life of approved cancer medicines, the IPHA, which represents 44 research based pharmaceutical companies in Ireland, many of whom are providing key oncology medicines, has stated that new therapies have contributed to significant declines in cancer death rates around the world since its peak in 1991.